You just read:

Lin BioScience Licenses a Novel Anti-Cancer Therapy for Hematological Malignancies and Solid Tumors from Columbia University and Memorial Sloan Kettering Cancer Center

News provided by

Lin BioScience, Inc.

Mar 03, 2017, 11:00 ET